AI assistant
Sending…
FIBROGEN INC — Director's Dealing 2016
May 18, 2016
34576_dirs_2016-05-18_e9a8f2e6-ae2a-4463-9ab6-ec9e29eea75f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2016-05-16
Reporting Person: Cotroneo Pat (VP, Finance and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-16 | Common Stock | S | 6107 | $17.60 | Disposed | 141868 | Direct |
Footnotes
F1: Shares sold pursuant to a 10b5-1 plan.
F2: The shares were sold at prices ranging from $17.35 to $17.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Includes 1,389 shares purchased through the issuer's employee stock purchase plan on May 13, 2016.
More from FIBROGEN INC
Regulatory Filings
2026
Apr 9
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Nov 17
Major Shareholding Notification
2025
Nov 15
Interim / Quarterly Report
2025
Nov 10
Regulatory Filings
2025
Nov 10